Value of TP53 status for predicting response to neoadjuvant chemotherapy in breast cancer: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Value of TP53 status for predicting response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.

Value of TP53 status for predicting response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.

http://www.wikidata.org/entity/Q34328227

about

Relationship between p53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.Rational Manual and Automated Scoring Thresholds for the Immunohistochemical Detection of TP53 Missense Mutations in Human Breast Carcinomas.The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence.Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.Survival benefit of neoadjuvant chemotherapy for resectable breast cancer: A meta-analysis.

P2860

Q27852996-11CCBEF4-26F3-402C-A265-0D22D4ECB591 Q31150068-21528430-CED2-43C1-A2D4-18AAE615FA7A Q33614238-A0732B7B-4971-48C8-BDEA-078A2E9E0D13 Q35237197-AA7535F3-DF0C-4579-939E-D9033B3A28CF Q36474056-31550FD9-390A-4BEA-BE56-14D3F7082624 Q39018419-F4FBE2AB-24B3-407F-AC32-9DE32BC7BC55 Q42315543-D522A81B-99D9-45D0-BBFD-D4037F281098 Q55282718-A25C3C74-8260-4855-8D1C-56254231019D

P2860

Value of TP53 status for predicting response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.

http://www.wikidata.org/entity/Q34328227

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@ast

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@en

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@nl

type

label

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@ast

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@en

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@nl

prefLabel

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@ast

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@en

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@nl

P1433

Q34328227-22E700E7-05A8-41A9-A753-18BDD7857802

P1476

Q34328227-3E2B3458-3FEA-4EB5-9BF3-6DC0701225D9

P2093

Q34328227-0ACF5F84-1C75-4850-A4D0-8E30C4014FBA

Q34328227-265A981D-2DAE-4520-A01B-FD1161755F43

Q34328227-27F57BDB-568E-4484-B9DA-4EE52026366E

Q34328227-2C4B8524-3779-4B80-A157-09CF83B4DEE4

Q34328227-99856627-B447-48F8-A1D5-45916B9E63D3

Q34328227-F3A1E1B4-549E-4FF0-817E-5D0E08B1B9A5

Q34328227-F4FC3E40-2042-461E-B5A1-AC6EEFAA046A

P2860

Q34328227-00A88D34-44DA-46DB-8FF1-D559F3FA2B17

Q34328227-0C0193D0-3B52-4C12-B690-0F6C6E782BBA

Q34328227-0CCF7C6A-5C24-4AE7-A9FD-D05D3A9C0B7A

Q34328227-0D3C0F26-A23B-4BFE-AA44-4D025E6787CA

Q34328227-0DBEC82D-DA0A-4779-B341-4E56197317DA

Q34328227-1124CDBC-58BA-4134-B9AD-3EA41191D759

Q34328227-486988C9-91FF-469E-996C-CB7DDA109130

Q34328227-49669C12-07A1-472A-9FA7-5E1B66D3A9E4

Q34328227-4D8D8682-950C-4379-8AD6-06492B8B0288

Q34328227-50F85F7B-8A07-46BF-ABA7-D087B92C4D2B

P304

Q34328227-19F9A84E-1ECC-4E79-8548-6F50CC905AC3

P31

Q34328227-0A5E838C-0135-4AA4-824D-805FEB07CF0F

Q34328227-bca43ac7-f213-4129-b8f8-794e8ad50ae4

P356

Q34328227-3275139B-921D-46EF-AF02-EAC63C440822

P407

Q34328227-B98EB35F-17A3-4D91-ACC9-78D9D4251BF8

P433

Q34328227-83EDF0B5-EE6B-4028-A2DA-870FC3160404

P478

Q34328227-0CB34382-8D02-4EF9-A82D-F208419EDD5C

P577

Q34328227-77F47281-A395-4087-9EC1-3BD07237995F

P5875

Q34328227-20FDD7BD-473D-4EB3-B61E-A38CFDECBAA7

P698

Q34328227-B8422527-D5BF-4A07-BF34-82EE531737BD

P921

Q34328227-F9816324-CA55-43B9-B6CC-91F0E858028C

P932

Q34328227-D9C3A047-2C60-43B7-B923-E56F706ED00A

P356

JOURNAL.PONE.0039655

P1433

P1476

Value of TP53 status for predi ...... reast cancer: a meta-analysis.

@en

P2093

Chao-Ying Liu

http://www.w3.org/2001/XMLSchema#string

Jun-Ying Xu

http://www.w3.org/2001/XMLSchema#string

Li-Qiang Wang

http://www.w3.org/2001/XMLSchema#string

Min-Bin Chen

http://www.w3.org/2001/XMLSchema#string

Pei-Hua Lu

http://www.w3.org/2001/XMLSchema#string

Ya-Qun Zhu

http://www.w3.org/2001/XMLSchema#string

Zhang-Yi Ji

http://www.w3.org/2001/XMLSchema#string

P2860

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen

Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

Blinded by the Light: The Growing Complexity of p53

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

Reporting results of cancer treatment

TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.

HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination.

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

P304

e39655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0039655

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228331696

http://www.w3.org/2001/XMLSchema#string

P698

22768103

http://www.w3.org/2001/XMLSchema#string

P921

P932

3387248

http://www.w3.org/2001/XMLSchema#string